Reference 2018-629

REF:           2018-629

Subject:       Unlicensed medicines

 

Request:

1. Does your Trust have a policy on the use of unlicensed medicines? Please Answer Yes or No.  If yes, please provide a copy of the policy and all other relevant documentation

2. Does your Trust have a policy or protocol on obtaining informed consent from patients when an unlicensed medicine is used?  Please answer Yes or No. If yes, please provide copies of all relevant documentation including copies of template informed consent materials used to consent patients where an unlicensed medicine is to be administered.

3. Please state which Board level job role(s) is (are) responsible for patient safety and consenting.

4.  Does your Trust have, or intend to introduce, a policy that makes compounded bevacizumab routinely available to treat wet age-related macular degeneration?  If yes please supply a copy of your policy.

5. Does your Trust currently have a wholly NHS owned pharmacy with an aseptic unit for compounding/aliquotting medicines? Please answer Yes or NO.  If yes, is this NHS pharmacy the same legal entity as that of your hospital Trust?

6. Does your Trust currently host on its premises a privately owned pharmacy with an aseptic unit for compounding/aliquotting medicines?  Please answer Yes or NO. If yes, please provide details of the third party provider of your pharmacy services.

7. Over the past two years has your Trust, on more than one occasion, used compounded Avastin (bevacizumab) for ophthalmic use?  Please answer Yes or No.

 

If you answered yes to Q5 or Q6:

 

8. Is the pharmacy referred to above in Q5 or Q 6 currently providing, or potentially able to provide, compounded Avastin (bevacizumab) for ophthalmic use?  Please answer Yes or No

9. Does the pharmacy referred to above in Q5 or Q6 currently hold an MHRA license for the manufacture of specials? Please answer Yes or No

 

If you answered yes to Q5 or Q6 but no to Q9:

 

10. When was the pharmacy referred to above in answer to Q5 or Q6 last inspected by the CQC?

 

If you answered no to questions Q5 or Q6 above, but yes to question Q7:

 

11. Please provide information regarding from whom your Trust has or obtained/purchased  compounded Avastin (bevacizumab). If you cannot provide the name of any commercial supplier, please provide as much information as possible.

 

 

Response:

Please find information attached.

2018-629 – FOI Request – Unlicensed medicines [114 kb] PDF

Medicines Policy 2016 [2 mb] PDF

Visitor restrictions

To protect you and our staff during the current outbreak of Covid-19 we’ve put in place significant restrictions on hospital visitors.

Full details of these can be found on our website.

We would like to thank you for your understanding and helping us stop the spread of Covid-19.

Read More

Stay Home. Protect the NHS. Save Lives.

Close